Polymorphism in protease and reverse transcriptase and phenotypic drug resistance of HIV-1 recombinant CRFO2_AG isolates from patients with no prior use of Antiretroviral drugs in Abidjan, Cote d'Ivoire

被引：13

作者：

Adjé-Touré, C ^{[1
]}

Bilé, CE ^{[1
]}

Borget, MY ^{[1
]}

Hertog, K ^{[1
]}

Maurice, C ^{[1
]}

Nolan, ML ^{[1
]}

Nkengasong, JN ^{[1
]}

机构：

[1] Project RETRO CI, Abidjan, Cote Ivoire

来源：

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2003年 / 34卷 / 01期

关键词：

D O I：

10.1097/00126334-200309010-00016

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：111 / 113

页数：3

共 10 条

[1]

Adjé C, 2001, J ACQ IMMUN DEF SYND, V26, P501, DOI 10.1097/00126334-200104150-00018

[2]

ANDREWS J, 2000, J VIROL, V74, P10269

[3]

DJOMAND G, 2003, IN PRESS AIDS

[4] Human immunodeficiency virus type 1 group M protease in Cameroon: Genetic diversity and protease inhibitor mutational features [J].

Fonjungo, PN ;

Mpoudi, EN ;

Torimiro, JN ;

Alemnji, GA ;

Eno, LT ;

Lyonga, EJ ;

Nkengasong, JN ;

Lal, RB ;

Rayfield, M ;

Kalish, ML ;

Folks, TM ;

Pieniazek, D .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :837-845

[5] World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing [J].

Harrigan, PR ;

Montaner, JSG ;

Wegner, SA ;

Verbiest, W ;

Miller, V ;

Wood, R ;

Larder, BA .

AIDS, 2001, 15 (13) :1671-1677

[6] Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type β-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp. -: J Antimicrob Chemother 1998; 42:269-270 [J].

Vahaboglu, H ;

Saribas, S ;

Akbal, H ;

Ozturk, R ;

Yucel, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :269-270

[7] Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide [J].

Pieniazek, D ;

Rayfield, M ;

Hu, DJ ;

Nkengasong, J ;

Wiktor, SZ ;

Downing, R ;

Biryahwaho, B ;

Mastro, T ;

Tanuri, A ;

Soriano, V ;

Lal, R ;

Dondero, T .

AIDS, 2000, 14 (11) :1489-1495

[8] Primary HIV-1 drug resistance in Abidjan (Cote d'Ivoire):: a genotypic and phenotypic study [J].

Toni, TD ;

Masquelier, B ;

Bonard, D ;

Faure, M ;

Huët, C ;

Caumont, A ;

Roques, P ;

Dabis, F ;

Salamon, R ;

Fleury, H .

AIDS, 2002, 16 (03) :488-491

[9] Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: Evidence of many minor drug resistance mutations in treatment-naive patients [J].

Vergne, L ;

Peeters, M ;

Mpoudi-Ngole, E ;

Bourgeois, A ;

Liegeois, F ;

Toure-Kane, C ;

Mboup, S ;

Mulanga-Kabeya, C ;

Saman, E ;

Jourdan, J ;

Reynes, J ;

Delaporte, E .

JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (11) :3919-3925

[10] Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance [J].

Weidle, PJ ;

Malamba, S ;

Mwebaze, R ;

Sozi, C ;

Rukundo, G ;

Downing, R ;

Hanson, D ;

Ochola, D ;

Mugyenyi, P ;

Mermin, J ;

Samb, B ;

Lackritz, E .

LANCET, 2002, 360 (9326) :34-40

← 1 →